rs4636

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_182972.3(IRF2BP2):​c.828G>T​(p.Ala276=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.347 in 1,521,876 control chromosomes in the GnomAD database, including 94,643 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 7665 hom., cov: 33)
Exomes 𝑓: 0.35 ( 86978 hom. )

Consequence

IRF2BP2
NM_182972.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.425
Variant links:
Genes affected
IRF2BP2 (HGNC:21729): (interferon regulatory factor 2 binding protein 2) This gene encodes an interferon regulatory factor-2 (IRF2) binding protein that interacts with the C-terminal transcriptional repression domain of IRF2. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 1-234608667-C-A is Benign according to our data. Variant chr1-234608667-C-A is described in ClinVar as [Benign]. Clinvar id is 402983.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.425 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.358 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
IRF2BP2NM_182972.3 linkuse as main transcriptc.828G>T p.Ala276= synonymous_variant 1/2 ENST00000366609.4
IRF2BP2NM_001077397.1 linkuse as main transcriptc.828G>T p.Ala276= synonymous_variant 1/2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
IRF2BP2ENST00000366609.4 linkuse as main transcriptc.828G>T p.Ala276= synonymous_variant 1/21 NM_182972.3 P3Q7Z5L9-1
IRF2BP2ENST00000366610.7 linkuse as main transcriptc.828G>T p.Ala276= synonymous_variant 1/21 A1Q7Z5L9-2
ENST00000436039.1 linkuse as main transcriptn.631-754C>A intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.303
AC:
46099
AN:
152042
Hom.:
7666
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.180
Gnomad AMI
AF:
0.313
Gnomad AMR
AF:
0.334
Gnomad ASJ
AF:
0.424
Gnomad EAS
AF:
0.220
Gnomad SAS
AF:
0.267
Gnomad FIN
AF:
0.373
Gnomad MID
AF:
0.363
Gnomad NFE
AF:
0.362
Gnomad OTH
AF:
0.332
GnomAD3 exomes
AF:
0.356
AC:
46831
AN:
131388
Hom.:
8469
AF XY:
0.358
AC XY:
26743
AN XY:
74636
show subpopulations
Gnomad AFR exome
AF:
0.215
Gnomad AMR exome
AF:
0.304
Gnomad ASJ exome
AF:
0.436
Gnomad EAS exome
AF:
0.257
Gnomad SAS exome
AF:
0.298
Gnomad FIN exome
AF:
0.393
Gnomad NFE exome
AF:
0.401
Gnomad OTH exome
AF:
0.387
GnomAD4 exome
AF:
0.352
AC:
482618
AN:
1369716
Hom.:
86978
Cov.:
37
AF XY:
0.351
AC XY:
237540
AN XY:
677110
show subpopulations
Gnomad4 AFR exome
AF:
0.175
Gnomad4 AMR exome
AF:
0.299
Gnomad4 ASJ exome
AF:
0.419
Gnomad4 EAS exome
AF:
0.243
Gnomad4 SAS exome
AF:
0.282
Gnomad4 FIN exome
AF:
0.365
Gnomad4 NFE exome
AF:
0.365
Gnomad4 OTH exome
AF:
0.349
GnomAD4 genome
AF:
0.303
AC:
46106
AN:
152160
Hom.:
7665
Cov.:
33
AF XY:
0.305
AC XY:
22683
AN XY:
74380
show subpopulations
Gnomad4 AFR
AF:
0.180
Gnomad4 AMR
AF:
0.334
Gnomad4 ASJ
AF:
0.424
Gnomad4 EAS
AF:
0.220
Gnomad4 SAS
AF:
0.267
Gnomad4 FIN
AF:
0.373
Gnomad4 NFE
AF:
0.362
Gnomad4 OTH
AF:
0.332
Alfa
AF:
0.334
Hom.:
1574
Bravo
AF:
0.297
Asia WGS
AF:
0.247
AC:
860
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJan 24, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 47% of patients studied by a panel of primary immunodeficiencies. Number of patients: 45. Only high quality variants are reported. -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 29, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
Immunodeficiency, common variable, 14 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 19, 2021- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
9.6
DANN
Benign
0.91
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4636; hg19: chr1-234744413; COSMIC: COSV64014518; COSMIC: COSV64014518; API